We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
CareCloud
CCLD
$100M
| $697K | ﹤0.01% |
+83,850
| New | +$829K |
|
1802
DiaMedica Therapeutics
DMAC
$358M
| $695K | ﹤0.01% |
75,967
+16,096
| +27% | +$150K |
|
|
TECX
1803
Tectonic Therapeutic
TECX
$562M
| $695K | ﹤0.01% |
+4,566
| New | +$743K |
|
1804
Bank OZK
OZK
$5.62B
| $694K | ﹤0.01% |
+17,001
| New | +$669K |
|
|
EVA
1805
DELISTED
Enviva Inc.
EVA
| $689K | ﹤0.01% |
14,258
-27,287
| -66% | -$1.35M |
|
|
SEE
1806
DELISTED
Sealed Air
SEE
| $688K | ﹤0.01% |
15,015
-38,519
| -72% | -$1.72M |
|
1807
Legend Biotech
LEGN
$3.68B
| $686K | ﹤0.01% |
+23,622
| New | +$644K |
|
1808
Concrete Pumping Holdings
BBCP
$513M
| $685K | ﹤0.01% |
+92,466
| New | +$555K |
|
|
JIH
1809
DELISTED
Juniper Industrial Holdings, Inc.
JIH
| $676K | ﹤0.01% |
54,571
-994,012
| -95% | -$12.5M |
|
|
EGLE
1810
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $673K | ﹤0.01% |
+18,621
| New | +$527K |
|
1811
Entravision Communication
EVC
$1.01B
| $670K | ﹤0.01% |
+165,863
| New | +$573K |
|
1812
AudioCodes
AUDC
$249M
| $669K | ﹤0.01% |
24,789
-18,794
| -43% | -$558K |
|
1813
Simply Good Foods
SMPL
$941M
| $669K | ﹤0.01% |
22,017
+7,700
| +54% | +$229K |
|
1814
East-West Bancorp
EWBC
$18B
| $664K | ﹤0.01% |
8,996
-15,699
| -64% | -$1.07M |
|
1815
Hormel Foods
HRL
$14.1B
| $664K | ﹤0.01% |
13,890
-4,402
| -24% | -$208K |
|
1816
Protara Therapeutics
TARA
$221M
| $664K | ﹤0.01% |
+42,136
| New | +$781K |
|
|
CCRN
1817
DELISTED
Cross Country Healthcare
CCRN
| $663K | ﹤0.01% |
53,045
-60,095
| -53% | -$637K |
|
1818
Manhattan Associates
MANH
$9.95B
| $663K | ﹤0.01% |
+5,647
| New | +$684K |
|
1819
Labcorp
LH
$25.8B
| $662K | ﹤0.01% |
3,023
-2,750
| -48% | -$552K |
|
|
MANT
1820
DELISTED
Mantech International Corp
MANT
| $662K | ﹤0.01% |
+7,611
| New | +$663K |
|
1821
RLI Corp
RLI
$5.97B
| $660K | ﹤0.01% |
+11,824
| New | +$628K |
|
1822
EXL Service
EXLS
$4.66B
| $658K | ﹤0.01% |
+36,515
| New | +$623K |
|
1823
Western Union
WU
$2.58B
| $658K | ﹤0.01% |
+26,685
| New | +$628K |
|
|
LMNX
1824
DELISTED
Luminex Corp
LMNX
| $657K | ﹤0.01% |
20,606
-98,014
| -83% | -$2.91M |
|
1825
Alaska Air
ALK
$5.42B
| $656K | ﹤0.01% |
+9,472
| New | +$569K |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.